Skip to main content
. 2018 Oct 25;8:15752. doi: 10.1038/s41598-018-33982-y

Figure 8.

Figure 8

PHA-767491 does not sensitise non-AML HSCs to ABT-737. CD34+ non-malignant HSCs were isolated from four patients with non-AML disorders. These cells were cultured on an HS5-BMSC monolayer for 24 h and then treated with ABT-737 (30 and 300 nM) with or without a 4 h pre-treatment with the CDC7/CDK9 inhibitor, PHA-767491 (1–4 µM). Induction of cell death was quantified with To-Pro-3 staining and flow cytometry. The graphs show the percentage of live blasts. The effect of PHA-767491 alone is shown by the points on the Y axis (zero ABT-737 concentration) and the effect of ABT-737 alone is shown by the PHA 0 µM line (open circles).